GP
George Poste (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exelixis, Inc. (EXEL). The largest single filing was $2.7M of EXEL (60,000 sh × $45.71, as filed), executed May 7. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
May 7
Filed May 8
Median ADV $143.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
EXEL
Exelixis, Inc.
EXEL · 0 buys · 3 sells
3 filings
Recent filings
EXELSALE
Exelixis, Inc.
View filing →
$2.7M60,000 sh × $45.71
Exec May 7
Filed May 8 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $949K
20,634 sh × $45.99
Exec May 16 2025
Filed May 16 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $551K
15,874 sh × $34.74
Exec Feb 14 2025
Filed Feb 19 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. View filing → $1.0M
30,000 sh × $34.00
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET